Glycated hemoglobin (HbA1c) testing is one of the success stories of point-of-care diagnostics, and an area that will experience higher growth rates than other POC tests as a result of expert recommendations, new cases and booming mail-in test sales, according to a new Kalorama Information report.
Read MoreThe majority of new cancer tests coming to market are proprietary assays with the test services being provided by certified labs opened by the IVD companies that developed the test. This shift is leading to greater profits for those companies offering test services, notes health care market research publisher Kalorama Information.
Read More
CLP Speaks with David G. Rhoads and Gregory Vail of Data Innovations.
Read MoreBloodCenter of Wisconsins Diagnostic Laboratories announces the availability of a new test for ADAMTS13 antibodies to aid in the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Read MoreRoche Diagnostics has purchased assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow.
Read More